Prof. Dr. Mehmet Ali Vardar

 

ULUSLARARASI DERGİLERDE YAYINLANMIŞ MAKALELER

 

1)European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners-First Update 2015.

du Bois A, Reuss A, Pujade-Lauraine E, Pignata S, Ledermann J, Casado A, Sehouli J, Mirza M, Colombo N, Marth C, Witteveen E, Del Campo J, Calvert P, Aravantinos G, Vardar MA, van der Zee AG, Korach J, Taskiran C, Fehr M, Glasspool R, Pfisterer J, Cibula D, Vergote I; member trial groups of the European Network of Gynaecological Oncological Trial Groups (ENGOT).

Int J Gynecol Cancer. 2015 Jun 9. [Epub ahead of print]

2) The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma.

Kucukgoz Gulec U, Paydas S, Guzel AB, Vardar MA, Khatib G, Gumurdulu D.

Arch Gynecol Obstet. 2015 Apr 9. [Epub ahead of print

3) Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study.

Gungorduk K, Ertas IE, Ozdemir A, Akkaya E, Telli E, Taskin S, Gokcu M, Guzel AB, Oge T, Akman L, Toptas T, Solmaz U, Dogan A, Terek MC, Sanci M, Ozsaran A, Simsek T, Vardar MA, Yalcin OT, Ozalp S, Yildirim Y, Ortac F.

Cancer Res Treat. 2015 Jul;47(3):480-8. doi: 10.4143/crt.2014.058. Epub 2014 Nov 17.

4) Clinicopathological features and prognostic factors of the uterine sarcomas: 20 years of experience at Cukurova University.

Khatib G, Guzel AB, Gulec UK, Gumurdulu D, Vardar MA, Altintas A.

Eur J Gynaecol Oncol. 2014;35(6):646-54.

5) The relationship between ovarian volume and serum CA-125 levels.

Gulec UK, Paydas S, Guzel AB, Vardar MA, Urunsak IF, Cetin MT.

Eur J Gynaecol Oncol. 2014;35(3):280-3.

6) The guidance of intraoperative frozen section for staging surgery in endometrial carcinoma: frozen section in endometrial carcinoma.

Acikalin A, Gumurdulu D, Bagir EK, Torun G, Guzel AB, Zeren H, Vardar MA.

Pathol Oncol Res. 2015 Jan;21(1):119-22. doi: 10.1007/s12253-014-9796-4. Epub 2014 May 20.

7) Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.

Kucukgoz Gulec U, Gumurdulu D, Guzel AB, Paydas S, Seydaoglu G, Acikalin A, Khatib G, Zeren H, Vardar MA, Altintas A.

Arch Gynecol Obstet. 2014 Feb;289(2):393-8. doi: 10.1007/s00404-013-3000-z. Epub 2013 Aug 22.

 

8) Mature cystic teratoma of the fallopian tube.

Khatib G, Guzel AB, Kucukgoz-Gulec U, Vardar MA, Musaev A, Melekoglu R.

J Obstet Gynaecol. 2013 Feb;33(2):120-4. doi: 10.3109/01443615.2012.731452. Review.

9) Prognostic factors determining recurrence in early-stage endometrial cancer.

Misirlioglu S, Guzel AB, Gulec UK, Gumurdulu D, Vardar MA.

Eur J Gynaecol Oncol. 2012;33(6):610-4.

10) Preoperative evaluation, clinical characteristics, and prognostic factors of nongenital metastatic ovarian tumors: review of 48 patients.

Guzel AB, Gulec UK, Paydas S, Khatib G, Gumurdulu D, Vardar MA, Altintas A.

Eur J Gynaecol Oncol. 2012;33(5):493-7.

11) A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer.

Dursun P, Erkanli S, Güzel AB, Gultekin M, Tarhan NC, Altundag O, Demirkiran F, Beşe T, Yildirim Y, Bozdag G, Yarali H, Simsek T, Ozcelik B, Ortaç F, Taskin S, Guvenal T, Ozgul N, Haberal A, Vardar MA, Dede M, Yenen M, Altintas A, Arvas M, Ayhan A.

Int J Gynaecol Obstet. 2012 Dec;119(3):270-3. doi: 10.1016/j.ijgo.2012.06.010. Epub 2012 Aug 24. Review.

12) Adenosine deaminase activity in patients with ovarian neoplasms.

Urunsak IF, Gulec UK, Paydas S, Seydaoglu G, Guzel AB, Vardar MA.

Arch Gynecol Obstet. 2012 Jul;286(1):155-9. doi: 10.1007/s00404-012-2279-5. Epub 2012 Mar 7.

13) Comparative analysis of CA 125, ferritin, beta-2 microglobulin, lactic dehydrogenase levels in serum and peritoneal fluid in patients with ovarian neoplasia.

Kucukgoz Gulec U, Paydas S, Guzel AB, Buyukkurt S, Seydaoglu G, Vardar MA.

Med Oncol. 2012 Dec;29(4):2937-43. doi: 10.1007/s12032-012-0165-4. Epub 2012 Jan 25.

14) Heterogeneity in recurrent complete hydatidiform mole: presentation of two new Turkish families with different genetic characteristics.

Buyukkurt S, Fisher RA, Vardar MA, Evruke C.

Placenta. 2010 Nov;31(11):1023-5. doi: 10.1016/j.placenta.2010.09.003. Epub 2010 Sep 26.

15) Fallopian tube carcinoma metastatic to the pericardium and breast.

Buyukkurt S, Vardar MA, Zeren H, Guzel B, Tuncer I.

Eur J Gynaecol Oncol. 2009;30(3):335-7.

16) Mullerian adenosarcoma of the uterine cervix in an adolescent girl.

Buyukkurt S, Guzel AB, Gumurdulu D, Vardar MA, Zeren H, Sucu M.

J Pediatr Adolesc Gynecol. 2010 Feb;23(1):e13-5. doi: 10.1016/j.jpag.2009.05.008. Epub 2009 Jul 29.

17) Prevalence of cervical cytological abnormalities in Turkey.

Turkish Cervical Cancer And Cervical Cytology Research Group.

Int J Gynaecol Obstet. 2009 Sep;106(3):206-9. doi: 10.1016/j.ijgo.2009.04.003. Epub 2009 Jun 21.

18) A case with diffuse uterine leiomyomatosis and review of the literature.

Coskun A, Ozdemir O, Vardar MA, Kiran G, Arikan D, Ersoz C.

Clin Exp Obstet Gynecol. 2008;35(3):227-30. Review.

19) A comparative study of the analgesic effect of patient-controlled morphine, pethidine, and tramadol for postoperative pain management after abdominal hysterectomy.

Unlugenc H, Vardar MA, Tetiker S.

Anesth Analg. 2008 Jan;106(1):309-12, table of contents. doi: 10.1213/01.ane.0000287815.32869.2a.

20) The use of a silicone-coated acrylic vaginal stent in McIndoe vaginoplasty and review of the literature concerning silicone-based vaginal stents: a case report.

Coskun A, Coban YK, Vardar MA, Dalay AC.

BMC Surg. 2007 Jul 10;7:13.

21) Non-puerperal inversion of the uterus caused by leiomyosarcoma: a case report and clinical management.

Buyukkurt S, Vardar MA, Zeren H, Ozgunen FT.

J Obstet Gynaecol Res. 2007 Jun;33(3):402-6. Review.

22) Fine needle aspiration cytology of ovarian lesions.

Uguz A, Ersoz C, Bolat F, Gokdemir A, Vardar MA.

Acta Cytol. 2005 Mar-Apr;49(2):144-8.

23) Tuba uterina leukemia inhibitory factor concentration does not increase in tubal pregnancy: a preliminary study.

Kiran G, Kiran H, Ertopcu K, Kilinc M, Ekerbicer HC, Vardar MA.

Fertil Steril. 2005 Feb;83(2):484-6.

24) Efficacy of gemcitabine in heavily pretreated advanced ovarian cancer patients.

Bilgin T, Ozalp S, Yalçin OT, Zorlu G, Vardar MA, Ozerkan K.

Eur J Gynaecol Oncol. 2003;24(2):169-70.

25) Central nervous system involvement in gestational trophoblastic neoplasia.

Altintaş A, Vardar MA.

Eur J Gynaecol Oncol. 2001;22(2):154-6.

26) Pregnancy outcomes in young Turkish women.

Demir SC, Kadyýfçý O, Ozgünen T, Evrüke C, Vardar MA, Karaca A, Seydaŏlu G.

J Pediatr Adolesc Gynecol. 2000 Nov;13(4):177-81.

27) Dysfunctional uterine bleeding and other menstrual problems of secondary school students in Adana, Turkey.

Demir SC, Kadayýfçý TO, Vardar MA, Atay Y.

J Pediatr Adolesc Gynecol. 2000 Nov;13(4):171-5.

28) Gestational trophoblastic disease: the significance of vaginal metastases.

Vardar MA, Altintaş A, Demir SC.

Eur J Gynaecol Oncol. 2000;21(2):184-6.

29) Intraoperative assessment of depth of myometrial invasion in endometrial carcinoma.

Altintas A, Cosar E, Vardar MA, Demir C, Tuncer I.

Eur J Gynaecol Oncol. 1999;20(4):329-31.

30) Results of cytogenetic investigation in adolescent patients with primary or secondary amenorrhea.

Temoçin K, Vardar MA, Süleymanova D, Ozer E, Tanriverdi N, Demirhan O, Kadayifçi O.

J Pediatr Adolesc Gynecol. 1997 May;10(2):86-8.

31) Choriocarcinoma metastatic to the maxillary gingiva.

Altintas A, Vardar MA, Aridoğan N, Doran F, Tuncer I.

Eur J Surg Oncol. 1995 Oct;21(5):579-80.

32) Fraser syndrome.

Ozgünen T, Evrüke C, Kadayifçi O, Demir C, Aridoğan N, Vardar MA.

Int J Gynaecol Obstet. 1995 May;49(2):187-9.

 

33) Human papillomavirus detection in cervical smears and cervical tissue excised by the Loop Electrosurgical Excision Procedure (LEEP). Diagnostic value of cytology, colposcopy and histology.

Vardar MA, Altintas A, Doran F, Aridogan N, Demir C, Burgut R, Varinli S.

Eur J Gynaecol Oncol. 1995;16(6):494-9.

34) Is it essential to perform complete paraaortic lymph node dissection if no metastases have been shown in the lower part of the aorta?

Altintas A, Vardar MA, Evrüke C, Aridogan N.

Eur J Gynaecol Oncol. 1995;16(2):120-2.

35) Placental-site trophoblastic tumor. Principles of diagnosis, clinical behaviour and treatment.

Vardar MA, Altintas A.

Eur J Gynaecol Oncol. 1995;16(4):290-5.

36) Copper, zinc, and magnesium tissue and serum levels in patients with cervical carcinoma.

Altintas A, Vardar MA, Gönlüsen F, Atay Y, Evrüke C, Arpaci A, Aridogan N.

Eur J Gynaecol Oncol. 1995;16(4):278-81.

37) Etiology of serum CA-125 in patients with endometriosis treated with a gonadotrophin-releasing hormone agonist (Buserelin).

Cetin T, Vardar MA, Demir C, Burgut R.

Gynecol Obstet Invest. 1994;38(4):249-52.

38)Role of Chlamydia trachomatis infections in infertility due to tubal factor.

Cetin MT, Vardar MA, Aridogan N, Köksal F, Kiliç B, Burgut R.

Indian J Med Res. 1992 May;95:139-43.